Suppr超能文献

巴氯芬泵的使用:早期脊柱侧凸生长友好型器械治疗后的并发症。

Baclofen Pump Use: Complications After Growth-friendly Instrumentation for Early-onset Scoliosis.

机构信息

Departments of Orthopaedic Surgery.

Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH.

出版信息

J Pediatr Orthop. 2022 Feb 1;42(2):77-82. doi: 10.1097/BPO.0000000000002035.

Abstract

BACKGROUND

Patients with early-onset scoliosis (EOS) and spasticity may receive treatment with an intrathecal baclofen pump. We assessed how baclofen pumps are associated with the odds of complications and secondary interventions after growth-friendly (GF) spine surgery for EOS and analyzed infectious complications within the pump cohort.

METHODS

Using a prospectively maintained, international multicenter database, we studied patients with neuromuscular EOS with baclofen pumps who underwent GF spine surgery from 2002 through 2019 (n=25). Baclofen pumps were implanted before GF instrumentation in 18 patients, during in 2 patients, and after in 5 patients. Patients with existing pumps at initial GF spine surgery were matched 1:3 with 54 patients (control group) without pumps according to treatment center, year of surgery, diagnosis, surgery type, and preoperative curve magnitude. Univariate analysis and multivariate logistic regression were performed to compare complications and secondary interventions between the 2 cohorts.

RESULTS

Patients with baclofen pumps had 4.8 times the odds [95% confidence interval (CI): 1.5-16] of experiencing any complication within 1 year after initial GF spine surgery compared with controls. During mean follow-up of 6.9±4.3 years, they had 4.7 times the odds (95% CI: 1.3-16) of deep surgical site infection and 5.6 times the odds (95% CI: 1.2-26) of spinal rod removal after any complication. Differences in rates of mechanical complication, such as rod migration and breakage, were nonsignificant between the 2 groups. For the 9 patients (50%) with pumps who experienced infections, the most common microorganisms were Staphylococcus aureus (4 patients) and Pseudomonas aeruginosa (2). The pump/catheter was revised or removed, in addition to antibiotic therapy or surgical irrigation and debridement, in 2 patients.

CONCLUSIONS

Among patients with neuromuscular EOS, those with baclofen pumps are much more likely to experience complications within 1 year after GF spine surgery. They are also more likely to have deep surgical site infections, with S. aureus and P. aeruginosa being the most common causative organisms, and to require spinal rod removal.

LEVEL OF EVIDENCE

Level III-retrospective comparative study.

摘要

背景

患有早发性脊柱侧凸(EOS)和痉挛的患者可能需要接受鞘内巴氯芬泵治疗。我们评估了鞘内巴氯芬泵与 EOS 生长友好型(GF)脊柱手术后并发症和二次干预的几率之间的关系,并分析了泵组中的感染性并发症。

方法

使用前瞻性维护的国际多中心数据库,我们研究了 2002 年至 2019 年期间接受 GF 脊柱手术的神经肌肉性 EOS 伴巴氯芬泵的患者(n=25)。18 例患者在 GF 器械植入前植入巴氯芬泵,2 例患者在术中植入,5 例患者在术后植入。在初始 GF 脊柱手术时已有泵的患者根据治疗中心、手术年份、诊断、手术类型和术前曲度大小与 54 例无泵的患者(对照组)进行 1:3 匹配。对两组患者的并发症和二次干预进行单因素分析和多因素逻辑回归分析。

结果

与对照组相比,初始 GF 脊柱手术后 1 年内,有巴氯芬泵的患者发生任何并发症的几率增加 4.8 倍(95%置信区间[CI]:1.5-16)。在平均 6.9±4.3 年的随访中,他们发生任何并发症后的深部手术部位感染的几率增加 4.7 倍(95%CI:1.3-16),脊柱棒移除的几率增加 5.6 倍(95%CI:1.2-26)。两组之间机械并发症(如棒迁移和断裂)的发生率无显著差异。在 9 名(50%)有泵且发生感染的患者中,最常见的微生物是金黄色葡萄球菌(4 名患者)和铜绿假单胞菌(2 名患者)。除抗生素治疗或手术冲洗和清创外,有 2 名患者还对泵/导管进行了修改或移除。

结论

在患有神经肌肉性 EOS 的患者中,在 GF 脊柱手术后 1 年内,有巴氯芬泵的患者发生并发症的几率更高。他们也更有可能发生深部手术部位感染,金黄色葡萄球菌和铜绿假单胞菌是最常见的病原体,需要移除脊柱棒。

证据水平

三级-回顾性比较研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验